Tarsus Pharmaceuticals, Inc. ($TARS)
Filing Information
| Accession Number | 0001841401-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 19, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
12,440
Total Value
$850,417.03
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
General Counsel | Common Stock | โ | Mar 17, 2026 | Sale | 4,084 | $69.42 | $283,511.28 | 72,315 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Mar 18, 2026 | Sale | 4,125 | $68.71 | $283,428.75 | 68,190 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Mar 19, 2026 | Sale | 4,231 | $67.00 | $283,477.00 | 63,959 | Direct | โ | View Details |